FR22C1047I1 - BENZIMIDAZOLE-PROLINE DERIVATIVES - Google Patents
BENZIMIDAZOLE-PROLINE DERIVATIVESInfo
- Publication number
- FR22C1047I1 FR22C1047I1 FR22C1047C FR22C1047C FR22C1047I1 FR 22C1047 I1 FR22C1047 I1 FR 22C1047I1 FR 22C1047 C FR22C1047 C FR 22C1047C FR 22C1047 C FR22C1047 C FR 22C1047C FR 22C1047 I1 FR22C1047 I1 FR 22C1047I1
- Authority
- FR
- France
- Prior art keywords
- benzimidazole
- proline derivatives
- proline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12170748 | 2012-06-04 | ||
EP13158520 | 2013-03-11 | ||
PCT/IB2013/054567 WO2013182972A1 (en) | 2012-06-04 | 2013-06-03 | Benzimidazole-proline derivatives |
EP13744805.6A EP2855453B1 (en) | 2012-06-04 | 2013-06-03 | Benzimidazole-proline derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
FR22C1047I1 true FR22C1047I1 (en) | 2022-10-14 |
FR22C1047I2 FR22C1047I2 (en) | 2023-08-18 |
Family
ID=48914370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR22C1047C Active FR22C1047I2 (en) | 2012-06-04 | 2022-09-13 | BENZIMIDAZOLE-PROLINE DERIVATIVES |
Country Status (33)
Country | Link |
---|---|
US (3) | US9732075B2 (en) |
EP (1) | EP2855453B1 (en) |
JP (1) | JP5814491B2 (en) |
KR (3) | KR101689093B1 (en) |
CN (1) | CN104334544B (en) |
AR (1) | AR091257A1 (en) |
AU (1) | AU2013273222B2 (en) |
BR (1) | BR112014030173B1 (en) |
CA (1) | CA2873341C (en) |
CL (1) | CL2014003294A1 (en) |
CY (1) | CY1118735T1 (en) |
DK (1) | DK2855453T3 (en) |
EA (2) | EA028046B1 (en) |
ES (1) | ES2617863T3 (en) |
FR (1) | FR22C1047I2 (en) |
HK (1) | HK1208449A1 (en) |
HR (1) | HRP20170351T1 (en) |
HU (2) | HUE031753T2 (en) |
IL (1) | IL236024A (en) |
LT (2) | LT2855453T (en) |
MX (1) | MX354102B (en) |
MY (1) | MY169986A (en) |
NL (1) | NL301197I2 (en) |
NO (1) | NO2022044I1 (en) |
NZ (1) | NZ703448A (en) |
PH (1) | PH12014502540A1 (en) |
PL (1) | PL2855453T3 (en) |
PT (1) | PT2855453T (en) |
SG (2) | SG11201408004SA (en) |
SI (1) | SI2855453T1 (en) |
TW (2) | TWI570120B (en) |
WO (1) | WO2013182972A1 (en) |
ZA (1) | ZA201409422B (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2807000C (en) | 2010-08-24 | 2018-12-04 | Actelion Pharmaceuticals Ltd | Proline sulfonamide derivatives as orexin receptor antagonists |
EP2855453B1 (en) | 2012-06-04 | 2016-12-07 | Actelion Pharmaceuticals Ltd. | Benzimidazole-proline derivatives |
CN104703980B (en) | 2012-10-10 | 2017-09-22 | 埃科特莱茵药品有限公司 | Belong to the orexin receptor antagonists of [adjacent double (miscellaneous) aryl] [base of 2 (double (miscellaneous) aryl) pyrrolidines 1] ketone derivatives |
KR20150130413A (en) | 2013-03-12 | 2015-11-23 | 액테리온 파마슈티칼 리미티드 | Azetidine amide derivatives as orexin receptor antagonists |
SG11201600504TA (en) | 2013-07-22 | 2016-02-26 | Actelion Pharmaceuticals Ltd | 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives |
PT3077389T (en) | 2013-12-03 | 2017-12-15 | Idorsia Pharmaceuticals Ltd | Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists |
UA119151C2 (en) * | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1 h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist |
LT3077391T (en) * | 2013-12-04 | 2018-10-25 | Idorsia Pharmaceuticals Ltd | Use of benzimidazole-proline derivatives |
KR20160124188A (en) * | 2014-02-20 | 2016-10-26 | 다케다 파머수티컬 컴패니 리미티드 | Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists |
TW201613864A (en) * | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
AR103399A1 (en) | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | DERIVATIVES OF (R) -2-METHYL-PIPERAZINE AS CXCR3 RECEIVER MODULATORS |
ES2709985T3 (en) * | 2015-01-15 | 2019-04-22 | Idorsia Pharmaceuticals Ltd | Hydroxyalkyl piperazine derivatives as modulators of the CXCR3 receptor |
AU2016295693B2 (en) | 2015-07-17 | 2020-05-21 | Sunshine Lake Pharma Co., Ltd. | Substituted quinazoline compounds and preparation and uses thereof |
TWI734702B (en) | 2015-10-01 | 2021-08-01 | 美商百歐克斯製藥公司 | Human plasma kallikrein inhibitors |
AU2016360245B2 (en) | 2015-11-23 | 2020-07-09 | Sunshine Lake Pharma Co., Ltd. | Octahydropyrrolo [3, 4-c] pyrrole derivatives and uses thereof |
CN110612291B (en) | 2017-05-03 | 2024-02-13 | 爱杜西亚药品有限公司 | Preparation of 2- ([ 1,2,3] triazol-2-yl) -benzoic acid derivatives |
WO2019002344A1 (en) | 2017-06-29 | 2019-01-03 | Lonza Guangzhou Nansha Ltd. | Method for preparation of alpha-methyl-l-proline |
WO2020007964A1 (en) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives |
WO2020007977A1 (en) | 2018-07-06 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | 7-trifluoromethyl-[1,4]diazepan derivatives |
CN108997308A (en) * | 2018-07-09 | 2018-12-14 | 西藏大学 | A kind of benzimidazoles derivative and its preparation method and application |
WO2020099511A1 (en) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Benzimidazole-2-methyl-morpholine derivatives |
EP4138822A1 (en) | 2020-04-19 | 2023-03-01 | Idorsia Pharmaceuticals Ltd | Medical use of daridorexant |
WO2022166768A1 (en) * | 2021-02-02 | 2022-08-11 | 南京明德新药研发有限公司 | Tetrahydropyrrolocyclic compound and application thereof |
WO2023160004A1 (en) * | 2022-02-25 | 2023-08-31 | 南京知和医药科技有限公司 | Fused-ring compound having analgesic activity, and preparation method therefor and use thereof |
TW202400149A (en) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives |
CN117736193A (en) * | 2023-12-19 | 2024-03-22 | 南京知和医药科技有限公司 | Deuterated condensed ring compound and preparation method and application thereof |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3282927A (en) | 1964-05-21 | 1966-11-01 | Bristol Myers Co | 5-phenyl-4-thiazolylpenicillins |
AUPQ253199A0 (en) | 1999-08-30 | 1999-09-23 | Fujisawa Pharmaceutical Co., Ltd. | Non-prostanoid prostaglandin I2-agonist |
DE60110066T2 (en) | 2000-06-16 | 2006-02-02 | Smithkline Beecham P.L.C., Brentford | Piperidines for use as orexin receptor agonists |
KR20030060904A (en) | 2000-10-06 | 2003-07-16 | 뉴로젠 코포레이션 | Benzimidazole and indole derivatives as CRF receptor modulators |
US6943160B2 (en) | 2000-11-28 | 2005-09-13 | Smithkline Beecham Plc | Morpholine derivatives as antagonists of orexin receptors |
US7432270B2 (en) | 2001-05-05 | 2008-10-07 | Smithkline Beecham P.L.C. | N-aroyl cyclic amines |
JP2004534026A (en) | 2001-05-05 | 2004-11-11 | スミスクライン ビーチャム パブリック リミテッド カンパニー | N-aroyl cyclic amine derivatives as orexin receptor antagonists |
GB0115862D0 (en) | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
MXPA03011706A (en) * | 2001-06-28 | 2004-03-19 | Smithkline Beecham Plc | N-aroyl cyclic amine derivatives as orexin receptor antagonists. |
GB0124463D0 (en) | 2001-10-11 | 2001-12-05 | Smithkline Beecham Plc | Compounds |
GB0127145D0 (en) | 2001-11-10 | 2002-01-02 | Smithkline Beecham | Compounds |
GB0130393D0 (en) | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
GB0130335D0 (en) | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
DE10240818A1 (en) | 2002-08-30 | 2004-05-13 | Grünenthal GmbH | Substituted 2-pyrrolidin-2-yl [1,3,4] oxadiazole derivatives |
EP1539747B1 (en) | 2002-09-18 | 2006-11-02 | Glaxo Group Limited | N-aroyl cyclic amines as orexin receptor antagonists |
GB0225944D0 (en) | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
GB0225938D0 (en) | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
GB0225884D0 (en) | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
PE20050226A1 (en) | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | ARIL-HETEROAROMATIC PRODUCTS AND COMPOSITIONS CONTAINING THEM |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
AU2005250077B2 (en) | 2004-03-01 | 2011-06-09 | Idorsia Pharmaceuticals Ltd | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
WO2005113522A1 (en) | 2004-05-07 | 2005-12-01 | Janssen Pharmaceutica, N.V. | Azole carboxamide inhibitors of bacterial type iii protein secretion systems |
EP1604989A1 (en) | 2004-06-08 | 2005-12-14 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | DPP-IV inhibitors |
US20060019975A1 (en) | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
GB0510142D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
HUP0500920A2 (en) | 2005-10-05 | 2007-07-30 | Richter Gedeon Nyrt | Oxadiazole derivatives, process for their preparation and their use |
CA2644010A1 (en) | 2006-03-15 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Tetrahydroisoquinoline derivatives to enhance memory function |
AU2007272854B2 (en) | 2006-07-14 | 2013-08-01 | Merck Sharp & Dohme Corp. | Bridged diazepan orexin receptor antagonists |
US7994336B2 (en) | 2006-08-15 | 2011-08-09 | Actelion Pharmaceuticals Ltd. | Azetidine compounds as orexin receptor antagonists |
WO2008038251A2 (en) * | 2006-09-29 | 2008-04-03 | Actelion Pharmaceuticals Ltd | 3-aza-bicyclo[3.1.0]hexane derivatives |
US8124623B2 (en) | 2006-11-10 | 2012-02-28 | Actelion Pharmaceuticals Ltd. | 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials |
PE20081229A1 (en) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | DIAZEPAM OREXIN RECEPTOR ANTAGONISTS REPLACED |
TW200833328A (en) | 2006-12-28 | 2008-08-16 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.1.0]hexane derivatives |
WO2008087611A2 (en) | 2007-01-19 | 2008-07-24 | Actelion Pharmaceuticals Ltd | Pyrrolidine- and piperidine- bis-amide derivatives |
CL2008000836A1 (en) | 2007-03-26 | 2008-11-07 | Actelion Pharmaceuticals Ltd | Thiazolidine derivative compounds, orexin receptor antagonists; pharmaceutical composition that includes them; and its use in the treatment of emotional neurosis, severe depression, psychotic disorders, Alzheimer's, parkinson's, pain, among others. |
JP2010526869A (en) | 2007-05-14 | 2010-08-05 | アクテリオン ファーマシューティカルズ リミテッド | 2-cyclopropyl-thiazole derivatives |
US7741347B2 (en) | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2008150364A1 (en) | 2007-05-23 | 2008-12-11 | Merck & Co., Inc. | Cyclopropyl pyrrolidine orexin receptor antagonists |
GB0712888D0 (en) | 2007-07-03 | 2007-08-15 | Glaxo Group Ltd | Novel compounds |
EP2164847B1 (en) | 2007-07-03 | 2011-09-14 | Actelion Pharmaceuticals Ltd. | 3-aza-bicyclo[3.3.0]octane compounds |
AR067396A1 (en) | 2007-07-03 | 2009-10-07 | Glaxo Group Ltd | COMPOUND DERIVED FROM IMIDAZO (1,2-A) PIRIDIN-2-ILMETIL PIPERIDINA REPLACED HYDROCHLORIDE SALT OF THE SAME USE OF THE COMPOUND OR OF THE HYDROCHLORIDE SALT FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM |
US7751938B2 (en) | 2007-07-05 | 2010-07-06 | Panasonic Corporation | Robot arm control device and control method, robot, and control program |
DE602008004265D1 (en) | 2007-07-27 | 2011-02-10 | Actelion Pharmaceuticals Ltd | TRANS-3-azabicyclo-Ä3.1.0Ü-HEXANE DERIVATIVES |
AR067665A1 (en) | 2007-07-27 | 2009-10-21 | Actelion Pharmaceuticals Ltd | DERIVATIVES OF TRANS-3- AZA-BICYCLE (3.1.0) HEXANO |
NZ583487A (en) | 2007-07-27 | 2011-09-30 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.3.0]octane derivatives |
CA2699328A1 (en) | 2007-09-24 | 2009-04-02 | Actelion Pharmaceuticals Ltd | Pyrrolidines and piperidines as orexin receptor antagonists |
PE20091010A1 (en) | 2007-10-10 | 2009-08-08 | Actelion Pharmaceuticals Ltd | TETRAHYDROQUINOLINE DERIVATIVES |
PL2225231T3 (en) | 2007-12-18 | 2012-01-31 | Actelion Pharmaceuticals Ltd | Aminotriazole derivatives as alx agonists |
JP2011512400A (en) * | 2008-02-21 | 2011-04-21 | アクテリオン ファーマシューティカルズ リミテッド | 2-Aza-bicyclo [2.2.1] heptane derivatives |
GB0806536D0 (en) | 2008-04-10 | 2008-05-14 | Glaxo Group Ltd | Novel compounds |
CN102083827A (en) | 2008-07-07 | 2011-06-01 | 埃科特莱茵药品有限公司 | Thiazolidine compounds as orexin receptor antagonists |
WO2010038200A1 (en) | 2008-10-01 | 2010-04-08 | Actelion Pharmaceuticals Ltd | Oxazolidine compounds as orexin receptor antagonists |
KR20110071004A (en) | 2008-10-14 | 2011-06-27 | 액테리온 파마슈티칼 리미티드 | Phenethylamide derivatives and their heterocyclic analogues |
WO2010048012A1 (en) | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | 2,5-disubstituted piperidine orexin receptor antagonists |
JP2012509911A (en) | 2008-11-26 | 2012-04-26 | グラクソ グループ リミテッド | New compounds |
JP2012509910A (en) | 2008-11-26 | 2012-04-26 | グラクソ グループ リミテッド | New compounds |
EP2358713A1 (en) | 2008-11-26 | 2011-08-24 | Glaxo Group Limited | Imidazopyridazine derivatives acting as orexin antagonists |
CA2745433A1 (en) | 2008-12-02 | 2010-06-10 | Glaxo Group Ltd. | N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof |
JP2012510493A (en) | 2008-12-02 | 2012-05-10 | グラクソ グループ リミテッド | N-{[(IR, 4S, 6R) -3- (2-pyridinylcarbonyl) -3-azabicyclo [4.1.0] hept-4-yl] methyl} -2-heteroarylamine derivatives and their use |
GB0823467D0 (en) | 2008-12-23 | 2009-01-28 | Glaxo Group Ltd | Novel Compounds |
US20120035214A1 (en) | 2009-04-03 | 2012-02-09 | Merck Canada Inc. | Renin inhibitors |
CN102459229A (en) | 2009-04-24 | 2012-05-16 | 葛兰素集团有限公司 | 3-azabicyclo [4.1.0] heptanes used as orexin antagonists |
EP2440555B1 (en) | 2009-06-09 | 2016-05-18 | Actelion Pharmaceuticals Ltd | Fluorinated aminotriazole derivatives |
US8680275B2 (en) | 2009-10-23 | 2014-03-25 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
JP5759470B2 (en) | 2009-10-23 | 2015-08-05 | ヤンセン ファーマシューティカ エヌ.ベー. | Disubstituted octahydropyrrolo [3,4-c] pyrrole as an orexin receptor modulator |
JP5848251B2 (en) | 2009-10-23 | 2016-01-27 | ヤンセン ファーマシューティカ エヌ.ベー. | Fused heterocyclic compounds as orexin receptor modulators |
US8735384B2 (en) | 2010-01-19 | 2014-05-27 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
CA2807000C (en) | 2010-08-24 | 2018-12-04 | Actelion Pharmaceuticals Ltd | Proline sulfonamide derivatives as orexin receptor antagonists |
CA2812699A1 (en) | 2010-09-24 | 2012-03-29 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
US9242970B2 (en) | 2010-11-10 | 2016-01-26 | Actelion Pharmaceuticals Ltd. | Lactam derivatives useful as orexin receptor antagonists |
ES2541531T3 (en) | 2011-02-18 | 2015-07-21 | Actelion Pharmaceuticals Ltd. | New pyrazole and imidazole derivatives useful as orexin antagonists |
TWI565703B (en) | 2011-11-08 | 2017-01-11 | 艾克泰聯製藥有限公司 | 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives |
EP2855453B1 (en) * | 2012-06-04 | 2016-12-07 | Actelion Pharmaceuticals Ltd. | Benzimidazole-proline derivatives |
CN104703980B (en) | 2012-10-10 | 2017-09-22 | 埃科特莱茵药品有限公司 | Belong to the orexin receptor antagonists of [adjacent double (miscellaneous) aryl] [base of 2 (double (miscellaneous) aryl) pyrrolidines 1] ketone derivatives |
KR20150130413A (en) | 2013-03-12 | 2015-11-23 | 액테리온 파마슈티칼 리미티드 | Azetidine amide derivatives as orexin receptor antagonists |
PT3077389T (en) * | 2013-12-03 | 2017-12-15 | Idorsia Pharmaceuticals Ltd | Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists |
UA119151C2 (en) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1 h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist |
LT3077391T (en) | 2013-12-04 | 2018-10-25 | Idorsia Pharmaceuticals Ltd | Use of benzimidazole-proline derivatives |
-
2013
- 2013-06-03 EP EP13744805.6A patent/EP2855453B1/en active Active
- 2013-06-03 JP JP2015515624A patent/JP5814491B2/en active Active
- 2013-06-03 CA CA2873341A patent/CA2873341C/en active Active
- 2013-06-03 NZ NZ703448A patent/NZ703448A/en unknown
- 2013-06-03 AR ARP130101954 patent/AR091257A1/en active IP Right Grant
- 2013-06-03 KR KR1020157000154A patent/KR101689093B1/en active IP Right Grant
- 2013-06-03 TW TW104132248A patent/TWI570120B/en active
- 2013-06-03 HU HUE13744805A patent/HUE031753T2/en unknown
- 2013-06-03 SI SI201330557A patent/SI2855453T1/en unknown
- 2013-06-03 SG SG11201408004SA patent/SG11201408004SA/en unknown
- 2013-06-03 CN CN201380029097.2A patent/CN104334544B/en active Active
- 2013-06-03 TW TW102119632A patent/TWI510481B/en active
- 2013-06-03 PL PL13744805T patent/PL2855453T3/en unknown
- 2013-06-03 LT LTEP13744805.6T patent/LT2855453T/en unknown
- 2013-06-03 EA EA201401351A patent/EA028046B1/en not_active IP Right Cessation
- 2013-06-03 DK DK13744805.6T patent/DK2855453T3/en active
- 2013-06-03 MX MX2014014885A patent/MX354102B/en active IP Right Grant
- 2013-06-03 MY MYPI2014703599A patent/MY169986A/en unknown
- 2013-06-03 BR BR112014030173-5A patent/BR112014030173B1/en active IP Right Grant
- 2013-06-03 SG SG10201702540UA patent/SG10201702540UA/en unknown
- 2013-06-03 WO PCT/IB2013/054567 patent/WO2013182972A1/en active Application Filing
- 2013-06-03 KR KR1020187029604A patent/KR101995683B1/en active IP Right Grant
- 2013-06-03 ES ES13744805T patent/ES2617863T3/en active Active
- 2013-06-03 US US14/405,649 patent/US9732075B2/en active Active
- 2013-06-03 AU AU2013273222A patent/AU2013273222B2/en active Active
- 2013-06-03 KR KR1020167019098A patent/KR101946128B1/en active IP Right Grant
- 2013-06-03 EA EA201600366A patent/EA029899B1/en not_active IP Right Cessation
- 2013-06-03 PT PT137448056T patent/PT2855453T/en unknown
-
2014
- 2014-11-14 PH PH12014502540A patent/PH12014502540A1/en unknown
- 2014-12-02 CL CL2014003294A patent/CL2014003294A1/en unknown
- 2014-12-02 IL IL236024A patent/IL236024A/en active IP Right Grant
- 2014-12-19 ZA ZA2014/09422A patent/ZA201409422B/en unknown
-
2015
- 2015-09-16 HK HK15109034.2A patent/HK1208449A1/en unknown
-
2017
- 2017-02-28 CY CY20171100269T patent/CY1118735T1/en unknown
- 2017-03-02 HR HRP20170351TT patent/HRP20170351T1/en unknown
- 2017-07-07 US US15/644,547 patent/US10329287B2/en active Active
-
2019
- 2019-05-07 US US16/405,797 patent/US11040966B2/en active Active
-
2022
- 2022-08-31 LT LTPA2022518C patent/LTPA2022518I1/lt unknown
- 2022-09-01 HU HUS2200040C patent/HUS2200040I1/en unknown
- 2022-09-13 FR FR22C1047C patent/FR22C1047I2/en active Active
- 2022-09-28 NL NL301197C patent/NL301197I2/en unknown
- 2022-10-27 NO NO2022044C patent/NO2022044I1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR22C1047I2 (en) | BENZIMIDAZOLE-PROLINE DERIVATIVES | |
SMT201700065B (en) | PYRIDONIC DERIVATIVE | |
DK2859055T3 (en) | POLYMERCOATINGS | |
DK2825087T3 (en) | Otoscanner | |
DK2839013T3 (en) | NON-DISRUPTIVE-GEN-TARGETING | |
CO6990736A2 (en) | Substituted pyrrolidine-2-carboxamides | |
DK2873977T3 (en) | DOUBLE-RØRDISPENSER | |
DE112012006109A5 (en) | Okklusionsschienenanordnung | |
DK2854722T3 (en) | STOMIPOSE | |
AR092198A1 (en) | DERIVATIVES OF PIRAZOLOPIRIMIDINAS | |
CO7020919A2 (en) | Tetrahydroquinazolinone derivatives | |
DK2825157T3 (en) | AMINOSYRELIPIDER | |
CO6960557A2 (en) | 2-iodo-imidazole derivatives | |
DK2831122T3 (en) | Anthocyanidin-complex | |
DE112012006214T8 (en) | Wulstringwickler | |
CO7020920A2 (en) | Substituted Phenylazole Derivative | |
DE112012005566T8 (en) | Seltenerdnanoverbundmagnet | |
FI20126082A (en) | Gasväxelventilarrangemang | |
DK2885638T3 (en) | MOLECULENET | |
DK2858657T3 (en) | FEIJOAFRUKTEKSTRAKT | |
FI20126157A (en) | Laajentumistila | |
FI20125844A (en) | Hustekniksmodul | |
ES1077590Y (en) | COLUMBARY | |
FR2999576B1 (en) | TESTOSTERONE DERIVATIVES | |
DE102013212400A8 (en) | ABDECKPLATTENSTÜTZBAUGRUPPE |